Varex Imaging Corporation reports fourth quarter revenue of $229 million and fiscal year 2025 revenue of $845 million
Reuters
Nov 19, 2025
<a href="https://laohu8.com/S/VREX">Varex Imaging Corporation</a> reports fourth quarter revenue of $229 million and fiscal year 2025 revenue of $845 million
Varex Imaging Corporation reported fourth quarter fiscal year 2025 revenues of $229.0 million, an 11% increase year-over-year. Medical segment revenue was $152.0 million, up 5%, while Industrial segment revenue was $77.0 million, up 25%. For the full fiscal year 2025, revenues reached $845.0 million, a 4% increase over the prior year. The company reported a GAAP net loss of $1.70 per diluted share for the year, while non-GAAP net income was $0.90 per diluted share. Cash flow from operations totaled $42.0 million for fiscal 2025. Varex highlighted growth in global CT tube sales in the Medical segment and sustained momentum in its Industrial segment, including over $55.0 million in cargo systems orders and shipment of more than 15 new systems. The company also advanced photon counting technology for CT and launched a new radiographic detector from its facility in India.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Varex Imaging Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20251118780346) on November 18, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.